Joincare Pharmaceutical Group Industry Co Ltd (600380) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.045x

Based on the latest financial reports, Joincare Pharmaceutical Group Industry Co Ltd (600380) has a cash flow conversion efficiency ratio of 0.045x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.09 Billion ≈ $159.61 Million USD) by net assets (CN¥24.08 Billion ≈ $3.52 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Joincare Pharmaceutical Group Industry C's balance sheet to measure how much of total assets are equity-financed.

Joincare Pharmaceutical Group Industry Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)

This chart illustrates how Joincare Pharmaceutical Group Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Joincare Pharmaceutical Group Industry C cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Joincare Pharmaceutical Group Industry Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Joincare Pharmaceutical Group Industry Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Beijing Haohua Energy Resource Co Ltd
SHG:601101
0.042x
Vapores
SN:VAPORES
-0.073x
Air France-KLM SA
PA:AF
0.825x
Seadrill Limited
NYSE:SDRL
-0.014x
Worthington Industries Inc
NYSE:WOR
0.053x
CREDITACCESS GRAMEEN LIMITED
NSE:CREDITACC
0.043x
Ratch Group Public Company Limited
BK:RATCH
0.054x
Brookfield Wealth Solutions Ltd.
NYSE:BNT
0.026x

Annual Cash Flow Conversion Efficiency for Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Joincare Pharmaceutical Group Industry Co Ltd from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see 600380 stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥24.37 Billion
≈ $3.57 Billion
CN¥3.89 Billion
≈ $569.50 Million
0.160x +2.78%
2024-12-31 CN¥23.40 Billion
≈ $3.42 Billion
CN¥3.64 Billion
≈ $532.11 Million
0.155x -10.46%
2023-12-31 CN¥22.64 Billion
≈ $3.31 Billion
CN¥3.93 Billion
≈ $574.92 Million
0.174x -3.93%
2022-12-31 CN¥22.02 Billion
≈ $3.22 Billion
CN¥3.98 Billion
≈ $582.06 Million
0.181x +42.22%
2021-12-31 CN¥20.18 Billion
≈ $2.95 Billion
CN¥2.56 Billion
≈ $375.06 Million
0.127x -19.23%
2020-12-31 CN¥19.24 Billion
≈ $2.81 Billion
CN¥3.02 Billion
≈ $442.65 Million
0.157x +18.21%
2019-12-31 CN¥17.38 Billion
≈ $2.54 Billion
CN¥2.31 Billion
≈ $338.38 Million
0.133x +18.75%
2018-12-31 CN¥16.30 Billion
≈ $2.38 Billion
CN¥1.83 Billion
≈ $267.13 Million
0.112x -18.44%
2017-12-31 CN¥13.62 Billion
≈ $1.99 Billion
CN¥1.87 Billion
≈ $273.69 Million
0.137x -22.04%
2016-12-31 CN¥9.33 Billion
≈ $1.37 Billion
CN¥1.64 Billion
≈ $240.65 Million
0.176x +1.80%
2015-12-31 CN¥7.31 Billion
≈ $1.07 Billion
CN¥1.26 Billion
≈ $185.05 Million
0.173x +15.58%
2014-12-31 CN¥6.54 Billion
≈ $957.23 Million
CN¥979.46 Million
≈ $143.33 Million
0.150x +41.93%
2013-12-31 CN¥6.02 Billion
≈ $881.55 Million
CN¥635.52 Million
≈ $93.00 Million
0.105x -19.69%
2012-12-31 CN¥5.59 Billion
≈ $818.10 Million
CN¥734.36 Million
≈ $107.46 Million
0.131x +10.27%
2011-12-31 CN¥5.46 Billion
≈ $798.94 Million
CN¥650.36 Million
≈ $95.17 Million
0.119x -42.70%
2010-12-31 CN¥5.32 Billion
≈ $778.05 Million
CN¥1.11 Billion
≈ $161.74 Million
0.208x +51.08%
2009-12-31 CN¥4.40 Billion
≈ $644.12 Million
CN¥605.66 Million
≈ $88.63 Million
0.138x +16.78%
2008-12-31 CN¥3.86 Billion
≈ $565.10 Million
CN¥455.01 Million
≈ $66.58 Million
0.118x +11.73%
2007-12-31 CN¥4.07 Billion
≈ $595.64 Million
CN¥429.26 Million
≈ $62.81 Million
0.105x +11.54%
2006-12-31 CN¥2.88 Billion
≈ $421.74 Million
CN¥272.50 Million
≈ $39.88 Million
0.095x -21.15%
2005-12-31 CN¥3.03 Billion
≈ $443.13 Million
CN¥363.13 Million
≈ $53.14 Million
0.120x +47.47%
2004-12-31 CN¥2.97 Billion
≈ $434.97 Million
CN¥241.71 Million
≈ $35.37 Million
0.081x +43.15%
2003-12-31 CN¥3.03 Billion
≈ $443.74 Million
CN¥172.25 Million
≈ $25.21 Million
0.057x -51.61%
2002-12-31 CN¥2.01 Billion
≈ $294.39 Million
CN¥236.13 Million
≈ $34.55 Million
0.117x +3.91%
2001-12-31 CN¥1.98 Billion
≈ $289.91 Million
CN¥223.79 Million
≈ $32.75 Million
0.113x -83.03%
2000-12-31 CN¥257.75 Million
≈ $37.72 Million
CN¥171.61 Million
≈ $25.11 Million
0.666x +15.13%
1999-12-31 CN¥189.89 Million
≈ $27.79 Million
CN¥109.82 Million
≈ $16.07 Million
0.578x --

About Joincare Pharmaceutical Group Industry Co Ltd

SHG:600380 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.68 Billion
CN¥18.31 Billion CNY
Market Cap Rank
#5254 Global
#928 in China
Share Price
CN¥10.01
Change (1 day)
-0.99%
52-Week Range
CN¥9.29 - CN¥13.66
All Time High
CN¥20.78
About

Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China and internationally. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and tradi… Read more